After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
IOVA belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Iovance Biotherapeutics Inc is $611.10M. A total of 5.68 million shares were traded on the day, compared to an average of 12.65M shares.
In the most recent transaction, Puri Raj K. bought 5,600 shares of IOVA for 1.74 per share on May 23 ’25. After the transaction, the Chief Regulatory Officer now owns 206,852 company shares. In a previous transaction on May 14 ’25, Vogt Frederick G bought 25,000 shares at 1.69 per share. IOVA shares that Interim CEO & General Counsel owns now total 374,646.
Among the insiders who sold shares, Maynard Ryan D disposed of 50,000 shares on Nov 12 ’24 at a per-share price of $10.06. This resulted in the Director holding 7,500 shares of IOVA after the transaction. In another insider transaction, Maynard Ryan D bought 50,000 shares at $10.06 per share on Nov 12 ’24.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, IOVA has a high of $12.51 and a low of $1.64.
As of this writing, IOVA has an earnings estimate of -$0.27 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$0.2 per share and a lower estimate of -$0.34.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. IOVA’s latest balance sheet shows that the firm has $504.41M in Cash & Short Term Investments as of fiscal 2021. There were $71.53M in debt and $89.20M in liabilities at the time. Its Book Value Per Share was $2.30, while its Total Shareholder’s Equity was $621.66M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
